{"id":168312,"date":"2024-01-20T02:36:14","date_gmt":"2024-01-20T07:36:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/novartis-lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced\/"},"modified":"2024-08-18T11:47:35","modified_gmt":"2024-08-18T15:47:35","slug":"novartis-lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/novartis-lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced.php","title":{"rendered":"Novartis Lutathera\u00ae significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced&#8230;"},"content":{"rendered":"<p><![CDATA[Basel, January 19, 2024 \u2013 Novartis today presented data from the Phase III NETTER-2 trial showing that Lutathera\u00ae (INN: lutetium (177Lu) oxodotreotide \/ USAN: lutetium Lu 177 dotatate) plus long-acting release (LAR) octreotide reduced the risk of disease progression or death by 72% as first-line therapy in patients with somatostatin receptor-positive (SSTR+) well-differentiated grade 2\/3 advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) versus high-dose octreotide LAR alone1. Data were presented at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium.]]><\/p>\n<p>Read the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/01\/19\/2812383\/0\/en\/Novartis-Lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced-gastroenteropancreatic-neuroendocrine-tumors.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Novartis Lutathera\u00ae significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced...\">Novartis Lutathera\u00ae significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the rest here: Novartis Lutathera\u00ae significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/novartis-lutathera-significantly-reduced-risk-of-disease-progression-or-death-by-72-as-first-line-treatment-for-patients-with-advanced.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168312","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168312"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168312"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168312\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}